Table 1.
Group comparison
| Group 1 (n = 27) | Group 2 (n = 13) | p-value | |
|---|---|---|---|
| Sex | 0.58 | ||
| Female | 16 (59.26%) | 8 (61.54%) | |
| Male | 11 (40.74%) | 5 (38.46%) | |
| Fracture-typea | 0.32 | ||
| Seinsheimer Type IIA | 3 | 2 | |
| Seinsheimer Type IIB | 1 | 2 | |
| Seinsheimer Type IIIA | 10 | 3 | |
| Seinsheimer Type IIIB | – | 1 | |
| Seinsheimer Type IV | 2 | – | |
| Seinsheimer Type V | 1 | – | |
| OTA-typea | 0.54 | ||
| 32A1 | 1 | 2 | |
| 32A2 | – | – | |
| 32A3 | 3 | 2 | |
| 32B2 | 10 | 4 | |
| 32B3 | 2 | – | |
| 32C2 | – | – | |
| 32C3 | 1 | – | |
| Trauma mechanismb | 0.61 | ||
| Low energy | 16 | 9 | |
| High energy | 6 | 3 | |
| Nonunion-type | 0.53 | ||
| hypertrophic | 3/27 (11.1%) | 2/13 (15.4%) | |
| atrophic | 24/27 (88.9%) | 11/13 (84.6%) | |
| Age | 64.96 ± 15.87 | 66.31 ± 12.66 | 0.35 |
| BMIc | 26.9 ± 5.41 | 29.91 ± 5.6 | 0.57 |
| Time to index procedure (months) | 10.37 ± 7.2 | 8.85 ± 5.77 | 0.67 |
| Prior surgeries per particpant | 0.22 ± 0.42 | 0.69 ± 1.18 | 0.21 |
| Mean operation time (minutes) | 156.74 ± 42.63 | 149.08 ± 41.36 | 0.59 |
| Number of red blood cell units tranfused | 2.96 ± 3.57 | 3.15 ± 3.46 | 0.87 |
| Lenght of hospital stay (days) | 14.74 ± 5.45 | 15.77 ± 8.64 | 0.89 |
| Diabetes mellitus | 3/27 (11.1%) | 0/13 (0%) | 0.54 |
| Steroid use | 3/27 (11.1%) | 0/13 (0%) | 0.54 |
| Smoking | 3/27 (11.1%) | 3/13 (23.1%) | 0.37 |
| Osteoporosis | 2/27(7.4%) | 3/13(23.1%) | 0.31 |
| Bony healing | 27/27(100%) | 10/13(76.92%) | 0.03 |
| Healing time (months) | 7.96 ± 6.53 | 23.11 ± 26.57 | 0.01 |
| Follow-up (months) | 21.48 ± 17.52 | 36.15 ± 50.7 | 0.54 |
aincomplete dataset; in 15 participants Information could not be gathered due to incomplete medical records at admission to our clinic
bincomplete dataset; in six participants Information could not be gathered due to incomplete medical records at admission to our clinic
cincomplete dataset; in one participant Information could not be gathered due to incomplete medical records at admission to our clinic